Comorbidity and survival disparities among black and white patients with breast cancer.

CONTEXT Reasons for the shorter survival of black breast cancer patients compared with their white counterparts are not completely understood. OBJECTIVE To evaluate the role of comorbidity in this racial disparity among breast cancer patients. DESIGN, SETTING, AND PATIENTS Historical cohort from the Henry Ford Health System (a large comprehensive health system in Detroit, Mich) followed up for a median of 10 years. Patients (n = 906) included 264 black (29.1%) and 642 white (70.9%) women diagnosed as having breast cancer between 1985 and 1990. Detailed comorbidity data (268 comorbidities) and study data were abstracted from medical records and institutional, Surveillance, Epidemiology, and End Results, and Michigan State registries. Associations were analyzed with logistic and Cox regression. MAIN OUTCOME MEASURES Breast cancer recurrence/progression and survival to death from all, breast cancer, and competing (non-breast cancer) causes. RESULTS Of blacks, 64 (24.9%) died of breast cancer and 95 (37.0%) died of competing causes. Comparable data for whites were 115 (18.3%) and 202 (32.1%). Blacks had worse all-cause survival (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.11-1.62), breast cancer-specific survival (HR, 1.47; 95% CI, 1.08-2.00), and competing-causes survival (HR, 1.27; 95% CI, 1.00-1.63). A total of 77 adverse comorbidities were associated with reduced survival. Adverse comorbidity count was associated with all-cause (adjusted HR, 1.29; 95% CI, 1.19-1.40) and competing-causes survival but was not associated with recurrence/progression or breast cancer-specific survival. At least 1 adverse comorbidity was observed in 221 (86.0%) blacks and 407 (65.7%) whites (odds ratio, 3.20; 95% CI, 2.17-4.72). Comparisons of unadjusted and comorbidity-adjusted HRs indicated that adverse comorbidity explained 49.1% of all-cause and 76.7% of competing-causes survival disparity. Diabetes and hypertension were particularly important in explaining disparity. CONCLUSIONS More black breast cancer patients die of competing causes than of breast cancer. Effective control of comorbidity in black breast cancer patients should help improve life expectancy and lead to a reduction in survival disparities.

[1]  C. Newschaffer,et al.  Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. , 1997, Journal of clinical epidemiology.

[2]  P. Kvale,et al.  In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. , 2004, Journal of clinical epidemiology.

[3]  Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco bay area. , 1997, Ethnicity & disease.

[4]  L. Newman,et al.  Impact of breast carcinoma on African‐American women , 2001, Cancer.

[5]  H. Dayal,et al.  Race and socio-economic status in survival from breast cancer. , 1982, Journal of chronic diseases.

[6]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.

[7]  David Machin,et al.  Survival Analysis: A Practical Approach , 1995 .

[8]  J. Coebergh,et al.  Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.

[9]  C. C. Johnson,et al.  Race and differences in breast cancer survival in a managed care population. , 1999, Journal of the National Cancer Institute.

[10]  D McLerran,et al.  Using administrative data to describe casemix: a comparison with the medical record. , 1994, Journal of clinical epidemiology.

[11]  Re Waller,et al.  Principles of Exposure Measurement in Epidemiology , 1994 .

[12]  N. Krieger,et al.  Social class and black-white differences in breast cancer survival. , 1986, American journal of public health.

[13]  R. Heller,et al.  Accuracy of administrative data to assess comorbidity in patients with heart disease. an Australian perspective. , 2001, Journal of clinical epidemiology.

[14]  R. Severson,et al.  Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. , 1997, American journal of obstetrics and gynecology.

[15]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[16]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[17]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[18]  W. Satariano.  Aging, comorbidity, and breast cancer survival: an epidemiologic view. , 1993, Advances in experimental medicine and biology.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[20]  R. Hiatt,et al.  Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.

[21]  R Yancik,et al.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. , 2001, JAMA.

[22]  L. Bouter,et al.  How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.

[23]  J. Krischer,et al.  Effects of health insurance and race on breast carcinoma treatments and outcomes , 2000, Cancer.

[24]  H. Hibshoosh,et al.  African‐American/White differences in breast carcinoma , 2005, Cancer.

[25]  W. Satariano,et al.  The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer , 1994, Annals of Internal Medicine.

[26]  W. Satariano.  Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. , 1992, Journal of gerontology.

[27]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[28]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[29]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[30]  L. Rajmil.  Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .

[31]  M. West,et al.  Racial differences in breast carcinoma survival , 2000, Cancer.

[32]  James B Semmens,et al.  Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. , 2004, Journal of clinical epidemiology.

[33]  G. Nagel,et al.  The impact of comorbidity on the survival of postmenopausal women with breast cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[34]  Michael Simoff,et al.  Impact of comorbidity on lung cancer survival , 2003, International journal of cancer.

[35]  S Greenland,et al.  Modeling and variable selection in epidemiologic analysis. , 1989, American journal of public health.

[36]  G. Lyman,et al.  Importance of race on breast cancer survival , 2006, Annals of Surgical Oncology.

[37]  A S Kosinski,et al.  A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. , 1999, Journal of clinical epidemiology.

[38]  S. Nathanson,et al.  Racial differences in the presentation and surgical management of breast cancer. , 1999, Surgery.

[39]  D.,et al.  Regression Models and Life-Tables , 2022 .

[40]  H. Freeman,et al.  Racial disparities in breast carcinoma survival rates , 2003, Cancer.

[41]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[42]  C. Howe,et al.  African‐American/White differences in breast carcinoma , 2004, Cancer.

[43]  C K Redmond,et al.  Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.

[44]  J. Cuzick,et al.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.

[45]  P. Tartter,et al.  Ethnic differences in risk and prognostic factors for breast cancer. , 1995, Cancer.